Continuous Glucose Monitoring in the Hospital

Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatic...

Full description

Bibliographic Details
Main Authors: M. Citlalli Perez-Guzman, Trisha Shang, Jennifer Y. Zhang, Donna Jornsay, David C. Klonoff
Format: Article
Language:English
Published: Academya Publishing Co. 2021-04-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:http://www.e-enm.org/upload/pdf/enm-2021-201.pdf
id doaj-c25e4fe6964d4156a086017a31b918a7
record_format Article
spelling doaj-c25e4fe6964d4156a086017a31b918a72021-05-03T04:12:38ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782021-04-0136224025510.3803/EnM.2021.2012146Continuous Glucose Monitoring in the HospitalM. Citlalli Perez-Guzman0Trisha Shang1Jennifer Y. Zhang2Donna Jornsay3David C. Klonoff4 Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, GA, USA Diabetes Technology Society, Burlingame, CA, USA Diabetes Technology Society, Burlingame, CA, USA Diabetes Program, Mills-Peninsula Medical Center, Burlingame, CA, USA Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USAContinuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatically and remotely supplement or replace assisted monitoring of blood glucose by bedside nurses can decrease: the amount of necessary nursing exposure to COVID-19 patients with diabetes; the amount of time required for obtaining blood glucose measurements, and the amount of personal protective equipment necessary for interacting with patients during the blood glucose testing. The United States Food and Drug Administration (FDA) is now exercising enforcement discretion and not objecting to certain factory-calibrated CGMs being used in a hospital setting, both to facilitate patient care and to obtain performance data that can be used for future regulatory submissions. CGMs can be used in the hospital to decrease the frequency of fingerstick point of care capillary blood glucose testing, decrease hyperglycemic episodes, and decrease hypoglycemic episodes. Most of the research on CGMs in the hospital has focused on their accuracy and only recently outcomes data has been reported. A hospital CGM program requires cooperation of physicians, bedside nurses, diabetes educators, and hospital administrators to appropriately select and manage patients. Processes for collecting, reviewing, storing, and responding to CGM data must be established for such a program to be successful. CGM technology is advancing and we expect that CGMs will be increasingly used in the hospital for patients with diabetes.http://www.e-enm.org/upload/pdf/enm-2021-201.pdfblood glucosecovid-19diabetes mellitusglucosehospitalsintensive care unitstechnology
collection DOAJ
language English
format Article
sources DOAJ
author M. Citlalli Perez-Guzman
Trisha Shang
Jennifer Y. Zhang
Donna Jornsay
David C. Klonoff
spellingShingle M. Citlalli Perez-Guzman
Trisha Shang
Jennifer Y. Zhang
Donna Jornsay
David C. Klonoff
Continuous Glucose Monitoring in the Hospital
Endocrinology and Metabolism
blood glucose
covid-19
diabetes mellitus
glucose
hospitals
intensive care units
technology
author_facet M. Citlalli Perez-Guzman
Trisha Shang
Jennifer Y. Zhang
Donna Jornsay
David C. Klonoff
author_sort M. Citlalli Perez-Guzman
title Continuous Glucose Monitoring in the Hospital
title_short Continuous Glucose Monitoring in the Hospital
title_full Continuous Glucose Monitoring in the Hospital
title_fullStr Continuous Glucose Monitoring in the Hospital
title_full_unstemmed Continuous Glucose Monitoring in the Hospital
title_sort continuous glucose monitoring in the hospital
publisher Academya Publishing Co.
series Endocrinology and Metabolism
issn 2093-596X
2093-5978
publishDate 2021-04-01
description Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatically and remotely supplement or replace assisted monitoring of blood glucose by bedside nurses can decrease: the amount of necessary nursing exposure to COVID-19 patients with diabetes; the amount of time required for obtaining blood glucose measurements, and the amount of personal protective equipment necessary for interacting with patients during the blood glucose testing. The United States Food and Drug Administration (FDA) is now exercising enforcement discretion and not objecting to certain factory-calibrated CGMs being used in a hospital setting, both to facilitate patient care and to obtain performance data that can be used for future regulatory submissions. CGMs can be used in the hospital to decrease the frequency of fingerstick point of care capillary blood glucose testing, decrease hyperglycemic episodes, and decrease hypoglycemic episodes. Most of the research on CGMs in the hospital has focused on their accuracy and only recently outcomes data has been reported. A hospital CGM program requires cooperation of physicians, bedside nurses, diabetes educators, and hospital administrators to appropriately select and manage patients. Processes for collecting, reviewing, storing, and responding to CGM data must be established for such a program to be successful. CGM technology is advancing and we expect that CGMs will be increasingly used in the hospital for patients with diabetes.
topic blood glucose
covid-19
diabetes mellitus
glucose
hospitals
intensive care units
technology
url http://www.e-enm.org/upload/pdf/enm-2021-201.pdf
work_keys_str_mv AT mcitlalliperezguzman continuousglucosemonitoringinthehospital
AT trishashang continuousglucosemonitoringinthehospital
AT jenniferyzhang continuousglucosemonitoringinthehospital
AT donnajornsay continuousglucosemonitoringinthehospital
AT davidcklonoff continuousglucosemonitoringinthehospital
_version_ 1721484400061841408